Randomized controlled trial

Moxibustion and acupuncture for the treatment of Crohn's disease

Chun Hui Bao, Ji Meng Zhao, Hui Rong Liu, Yuan Lu, Yi Fang Zhu, Yin Shi, Zhi Jun Weng, Hui Feng, Xin Guan, Jing Li, Wei Feng Chen, Lu Yi Wu, Xiaoming Jin, Chuan Zi Dou, Huan Gan Wu

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

AIM: To evaluate the clinical efficacy and safety of acupuncture and moxibustion for the treatment of active Crohn's disease (CD). METHODS: Ninety-two patients were equally and randomly divided into the treatment group and received herb-partitioned moxibustion combined with acupuncture, and the control group received wheat bran-partitioned moxibustion combined with superficial acupuncture. The patients received three treatment sessions per week for 12 wk and were followed up for 24 wk. The main outcome was evaluated using the CD Activity Index (CDAI) score, and the secondary outcomes were evaluated using laboratory indicators such as hemoglobin (HGB), C-reactive protein (CRP), erythrocyte sedimentation rate, quality-of-life, endoscopic ratings, and intestinal histology scores. RESULTS: The CDAI scores of both the treatment and control groups were significantly reduced after treatment compared with those measured before treatment. However, the degree of improvement in the treatment group was significantly greater than that of the control group. The improvement in symptoms in patients of the treatment group was sustained at follow-up, whereas that of the control group was not. The overall efficacy of the treatment was significantly greater than that of the control. Both groups demonstrated significant improvements in quality-of-life ratings after treatment, but the improvement was significantly greater in the treatment group than in the control group. In addition, the patients in the treatment group showed significantly increased HGB and significantly decreased CRP levels and histopathological scores at the end of treatment, whereas the control group did not exhibit significant changes. CONCLUSION: Moxibustion with acupuncture provided significant therapeutic benefits in patients with active CD beyond the placebo effect and is therefore an effective and safe treatment for active CD.

Original languageEnglish
Pages (from-to)11000-11011
Number of pages12
JournalWorld Journal of Gastroenterology
Volume20
Issue number31
DOIs
StatePublished - Aug 21 2014

Fingerprint

Acupuncture Therapy
Moxibustion
Crohn Disease
Randomized Controlled Trials
Control Groups
Therapeutics
Acupuncture
C-Reactive Protein
Hemoglobin C
Quality of Life
Placebo Effect
Blood Sedimentation
Dietary Fiber

Keywords

  • Acupuncture
  • Crohn's disease
  • Moxibustion
  • Randomized controlled trial
  • Traditional chinese medicine

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

Bao, C. H., Zhao, J. M., Liu, H. R., Lu, Y., Zhu, Y. F., Shi, Y., ... Wu, H. G. (2014). Randomized controlled trial: Moxibustion and acupuncture for the treatment of Crohn's disease. World Journal of Gastroenterology, 20(31), 11000-11011. https://doi.org/10.3748/wjg.v20.i31.11000

Randomized controlled trial : Moxibustion and acupuncture for the treatment of Crohn's disease. / Bao, Chun Hui; Zhao, Ji Meng; Liu, Hui Rong; Lu, Yuan; Zhu, Yi Fang; Shi, Yin; Weng, Zhi Jun; Feng, Hui; Guan, Xin; Li, Jing; Chen, Wei Feng; Wu, Lu Yi; Jin, Xiaoming; Dou, Chuan Zi; Wu, Huan Gan.

In: World Journal of Gastroenterology, Vol. 20, No. 31, 21.08.2014, p. 11000-11011.

Research output: Contribution to journalArticle

Bao, CH, Zhao, JM, Liu, HR, Lu, Y, Zhu, YF, Shi, Y, Weng, ZJ, Feng, H, Guan, X, Li, J, Chen, WF, Wu, LY, Jin, X, Dou, CZ & Wu, HG 2014, 'Randomized controlled trial: Moxibustion and acupuncture for the treatment of Crohn's disease', World Journal of Gastroenterology, vol. 20, no. 31, pp. 11000-11011. https://doi.org/10.3748/wjg.v20.i31.11000
Bao, Chun Hui ; Zhao, Ji Meng ; Liu, Hui Rong ; Lu, Yuan ; Zhu, Yi Fang ; Shi, Yin ; Weng, Zhi Jun ; Feng, Hui ; Guan, Xin ; Li, Jing ; Chen, Wei Feng ; Wu, Lu Yi ; Jin, Xiaoming ; Dou, Chuan Zi ; Wu, Huan Gan. / Randomized controlled trial : Moxibustion and acupuncture for the treatment of Crohn's disease. In: World Journal of Gastroenterology. 2014 ; Vol. 20, No. 31. pp. 11000-11011.
@article{6f9d0adc4f1849fc844b8e276a6f3ea6,
title = "Randomized controlled trial: Moxibustion and acupuncture for the treatment of Crohn's disease",
abstract = "AIM: To evaluate the clinical efficacy and safety of acupuncture and moxibustion for the treatment of active Crohn's disease (CD). METHODS: Ninety-two patients were equally and randomly divided into the treatment group and received herb-partitioned moxibustion combined with acupuncture, and the control group received wheat bran-partitioned moxibustion combined with superficial acupuncture. The patients received three treatment sessions per week for 12 wk and were followed up for 24 wk. The main outcome was evaluated using the CD Activity Index (CDAI) score, and the secondary outcomes were evaluated using laboratory indicators such as hemoglobin (HGB), C-reactive protein (CRP), erythrocyte sedimentation rate, quality-of-life, endoscopic ratings, and intestinal histology scores. RESULTS: The CDAI scores of both the treatment and control groups were significantly reduced after treatment compared with those measured before treatment. However, the degree of improvement in the treatment group was significantly greater than that of the control group. The improvement in symptoms in patients of the treatment group was sustained at follow-up, whereas that of the control group was not. The overall efficacy of the treatment was significantly greater than that of the control. Both groups demonstrated significant improvements in quality-of-life ratings after treatment, but the improvement was significantly greater in the treatment group than in the control group. In addition, the patients in the treatment group showed significantly increased HGB and significantly decreased CRP levels and histopathological scores at the end of treatment, whereas the control group did not exhibit significant changes. CONCLUSION: Moxibustion with acupuncture provided significant therapeutic benefits in patients with active CD beyond the placebo effect and is therefore an effective and safe treatment for active CD.",
keywords = "Acupuncture, Crohn's disease, Moxibustion, Randomized controlled trial, Traditional chinese medicine",
author = "Bao, {Chun Hui} and Zhao, {Ji Meng} and Liu, {Hui Rong} and Yuan Lu and Zhu, {Yi Fang} and Yin Shi and Weng, {Zhi Jun} and Hui Feng and Xin Guan and Jing Li and Chen, {Wei Feng} and Wu, {Lu Yi} and Xiaoming Jin and Dou, {Chuan Zi} and Wu, {Huan Gan}",
year = "2014",
month = "8",
day = "21",
doi = "10.3748/wjg.v20.i31.11000",
language = "English",
volume = "20",
pages = "11000--11011",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "31",

}

TY - JOUR

T1 - Randomized controlled trial

T2 - Moxibustion and acupuncture for the treatment of Crohn's disease

AU - Bao, Chun Hui

AU - Zhao, Ji Meng

AU - Liu, Hui Rong

AU - Lu, Yuan

AU - Zhu, Yi Fang

AU - Shi, Yin

AU - Weng, Zhi Jun

AU - Feng, Hui

AU - Guan, Xin

AU - Li, Jing

AU - Chen, Wei Feng

AU - Wu, Lu Yi

AU - Jin, Xiaoming

AU - Dou, Chuan Zi

AU - Wu, Huan Gan

PY - 2014/8/21

Y1 - 2014/8/21

N2 - AIM: To evaluate the clinical efficacy and safety of acupuncture and moxibustion for the treatment of active Crohn's disease (CD). METHODS: Ninety-two patients were equally and randomly divided into the treatment group and received herb-partitioned moxibustion combined with acupuncture, and the control group received wheat bran-partitioned moxibustion combined with superficial acupuncture. The patients received three treatment sessions per week for 12 wk and were followed up for 24 wk. The main outcome was evaluated using the CD Activity Index (CDAI) score, and the secondary outcomes were evaluated using laboratory indicators such as hemoglobin (HGB), C-reactive protein (CRP), erythrocyte sedimentation rate, quality-of-life, endoscopic ratings, and intestinal histology scores. RESULTS: The CDAI scores of both the treatment and control groups were significantly reduced after treatment compared with those measured before treatment. However, the degree of improvement in the treatment group was significantly greater than that of the control group. The improvement in symptoms in patients of the treatment group was sustained at follow-up, whereas that of the control group was not. The overall efficacy of the treatment was significantly greater than that of the control. Both groups demonstrated significant improvements in quality-of-life ratings after treatment, but the improvement was significantly greater in the treatment group than in the control group. In addition, the patients in the treatment group showed significantly increased HGB and significantly decreased CRP levels and histopathological scores at the end of treatment, whereas the control group did not exhibit significant changes. CONCLUSION: Moxibustion with acupuncture provided significant therapeutic benefits in patients with active CD beyond the placebo effect and is therefore an effective and safe treatment for active CD.

AB - AIM: To evaluate the clinical efficacy and safety of acupuncture and moxibustion for the treatment of active Crohn's disease (CD). METHODS: Ninety-two patients were equally and randomly divided into the treatment group and received herb-partitioned moxibustion combined with acupuncture, and the control group received wheat bran-partitioned moxibustion combined with superficial acupuncture. The patients received three treatment sessions per week for 12 wk and were followed up for 24 wk. The main outcome was evaluated using the CD Activity Index (CDAI) score, and the secondary outcomes were evaluated using laboratory indicators such as hemoglobin (HGB), C-reactive protein (CRP), erythrocyte sedimentation rate, quality-of-life, endoscopic ratings, and intestinal histology scores. RESULTS: The CDAI scores of both the treatment and control groups were significantly reduced after treatment compared with those measured before treatment. However, the degree of improvement in the treatment group was significantly greater than that of the control group. The improvement in symptoms in patients of the treatment group was sustained at follow-up, whereas that of the control group was not. The overall efficacy of the treatment was significantly greater than that of the control. Both groups demonstrated significant improvements in quality-of-life ratings after treatment, but the improvement was significantly greater in the treatment group than in the control group. In addition, the patients in the treatment group showed significantly increased HGB and significantly decreased CRP levels and histopathological scores at the end of treatment, whereas the control group did not exhibit significant changes. CONCLUSION: Moxibustion with acupuncture provided significant therapeutic benefits in patients with active CD beyond the placebo effect and is therefore an effective and safe treatment for active CD.

KW - Acupuncture

KW - Crohn's disease

KW - Moxibustion

KW - Randomized controlled trial

KW - Traditional chinese medicine

UR - http://www.scopus.com/inward/record.url?scp=84909641296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84909641296&partnerID=8YFLogxK

U2 - 10.3748/wjg.v20.i31.11000

DO - 10.3748/wjg.v20.i31.11000

M3 - Article

VL - 20

SP - 11000

EP - 11011

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 31

ER -